You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 22, December 12, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Medical Ethics
 •Statistics and Research Methods
 •Emergency Medicine
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Aiding Emergency Research Aim of Report on Exceptions to Informed Consent

Mike Mitka

JAMA. 2007;298(22):2608-2609.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Since 1996, when new US federal regulations required researchers and institutional review boards (IRBs) to obtain exceptions from standard informed consent for studies involving patients with emergency or life-threatening conditions, IRBs have been reluctant to approve such research, causing a limited number of such studies to be conducted. But new recommendations that offer a template to help IRBs and researchers designing trials meet these regulations may help remedy this situation.


Figure 70141FA
New recommendations may facilitate research on patients with medical emergencies who are unable to provide informed consent. (Photo credit: Medicine Today/Getty Images)

At issue is defining the ethical parameters for conducting research involving patients who cannot give informed consent (due to a medical condition such as cardiac arrest, stroke, or major trauma) but who may benefit from an experimental therapy or procedure, said Mark Siegler, MD, professor of medicine and director of the MacLean Center for Clinical Medical . . . [Full Text of this Article]

NEW RECOMMENDATIONS



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.